InvestorsHub Logo

crudeoil24

01/02/20 9:25 AM

#2586 RE: attenuation2 #2585

Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson
9:00 am ET January 2, 2020 (Benzinga) Print
https://ir.pulmatrix.com/2020-01-02-Pulmatrix-Announces-Kinase-Inhibitor-Licensing-Agreement-with-Lung-Cancer-Initiative-at-Johnson-Johnson

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.